BIOGEN INC. - COMMON STOCK (BIIB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
BIIB on Nasdaq
Shares outstanding
147,079,094
Price per share
$176.18
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
137,275,246
Total reported value
$24,155,390,401
% of total 13F portfolios
0.01%
Share change
+7,029,621
Value change
+$1,329,350,452
Number of holders
965
Price from insider filings
$176.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIOGEN INC. - COMMON STOCK (BIIB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 10% $2,094,853,956 14,954,697 PRIMECAP MANAGEMENT CO/CA/ 30 Sep 2025
BlackRock, Inc. 8.5% $1,502,927,856 12,506,681 BlackRock, Inc. 31 Mar 2025
FMR LLC 6.4% $1,656,604,787 9,413,062 FMR LLC 31 Dec 2025
STATE STREET CORP 5% $1,025,549,213 7,321,168 STATE STREET CORPORATION 30 Sep 2025

As of 31 Dec 2025, 965 institutional investors reported holding 137,275,246 shares of BIOGEN INC. - COMMON STOCK (BIIB). This represents 93% of the company’s total 147,079,094 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIOGEN INC. - COMMON STOCK (BIIB) together control 67% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 17,447,092 +0.91% 0.04% $3,070,513,721
BlackRock, Inc. 10% 14,811,370 +0.32% 0.04% $2,606,652,919
PRIMECAP MANAGEMENT CO/CA/ 10% 14,757,997 -1.3% 2% $2,597,259,895
FMR LLC 6.4% 9,425,863 +632% 0.08% $1,658,857,459
STATE STREET CORP 4.9% 7,159,020 -2.2% 0.04% $1,259,915,930
GEODE CAPITAL MANAGEMENT, LLC 2.9% 4,199,399 +3.2% 0.05% $736,434,804
WELLINGTON MANAGEMENT GROUP LLP 2.4% 3,551,269 -16% 0.11% $624,987,832
Point72 Asset Management, L.P. 1.9% 2,813,192 -27% 0.78% $495,093,660
NORGES BANK 1.8% 2,638,834 0.05% $464,408,396
MORGAN STANLEY 1.6% 2,325,013 +3.3% 0.02% $409,179,635
JPMORGAN CHASE & CO 1.3% 1,857,262 +46% 0.02% $326,859,629
Boston Partners 1.2% 1,720,595 0.31% $302,815,433
Invesco Ltd. 1.1% 1,655,441 -32% 0.04% $291,341,046
AQR CAPITAL MANAGEMENT LLC 1% 1,528,616 -14% 0.14% $269,021,112
Legal & General Group Plc 0.99% 1,459,597 -8.4% 0.06% $256,874,480
NORTHERN TRUST CORP 0.98% 1,446,126 -3.5% 0.03% $254,503,714
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.95% 1,391,370 -3.3% 0.05% $244,867,205
BARCLAYS PLC 0.89% 1,305,007 -4% 0.09% $229,668,181
T. Rowe Price Investment Management, Inc. 0.8% 1,170,907 +9.7% 0.13% $206,068,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.78% 1,143,902 +1.8% 0.03% $201,315,313
BANK OF AMERICA CORP /DE/ 0.77% 1,128,845 -7.5% 0.01% $198,665,432
MILLENNIUM MANAGEMENT LLC 0.77% 1,125,586 +1.3% 0.14% $198,091,880
GOLDMAN SACHS GROUP INC 0.75% 1,099,098 +3.3% 0.03% $193,430,233
VAN ECK ASSOCIATES CORP 0.72% 1,065,616 -0.12% 0.15% $187,538,000
Alyeska Investment Group, L.P. 0.7% 1,024,268 +21% 0.51% $180,260,925

Institutional Holders of BIOGEN INC. - COMMON STOCK (BIIB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 137,275,246 $24,155,390,401 +$1,329,350,452 $175.99 965
2025 Q3 130,394,386 $18,268,725,836 +$165,528,624 $140.08 891
2025 Q2 129,287,238 $16,238,624,437 +$284,309,412 $125.59 856
2025 Q1 127,028,107 $17,371,280,984 -$578,239,538 $136.84 865
2024 Q4 131,405,263 $20,085,982,511 +$272,768,825 $152.92 861
2024 Q3 128,615,457 $24,913,936,182 -$143,640,766 $193.84 903
2024 Q2 128,193,288 $29,710,612,652 -$84,741,446 $231.82 933
2024 Q1 128,518,741 $27,691,040,526 +$55,007,555 $215.63 932
2023 Q4 127,982,276 $33,111,816,739 +$901,376,761 $258.77 993
2023 Q3 124,470,870 $31,994,071,856 -$470,206,356 $257.01 954
2023 Q2 126,306,466 $35,966,219,806 +$277,366,431 $284.85 994
2023 Q1 125,053,711 $34,758,696,486 +$300,589,329 $278.03 987
2022 Q4 124,528,759 $34,492,440,417 +$242,887,240 $276.92 1,018
2022 Q3 123,323,995 $32,917,825,335 +$384,787,916 $267.00 966
2022 Q2 121,790,135 $24,840,540,438 -$152,960,663 $203.94 911
2022 Q1 122,616,063 $25,827,895,030 -$220,078,557 $210.60 941
2021 Q4 123,500,078 $29,628,123,955 -$101,746,917 $239.92 996
2021 Q3 123,461,166 $34,947,282,206 -$614,669,326 $282.99 1,026
2021 Q2 125,522,812 $43,460,004,330 -$566,581,701 $346.27 1,091
2021 Q1 127,388,312 $35,598,424,357 -$380,775,241 $279.75 1,079
2020 Q4 128,905,111 $31,559,604,046 -$521,085,738 $244.86 1,047
2020 Q3 130,781,613 $37,077,214,726 -$1,220,436,591 $283.68 1,036
2020 Q2 134,944,833 $36,078,566,447 -$2,622,299,974 $267.55 1,048
2020 Q1 144,371,093 $45,633,042,157 -$2,072,462,238 $316.38 1,090
2019 Q4 150,927,624 $44,753,934,396 -$2,257,146,159 $296.73 1,090
2019 Q3 159,069,579 $37,018,304,080 -$348,502,414 $232.82 972
2019 Q2 160,395,186 $37,502,672,698 -$2,138,732,747 $233.87 1,002
2019 Q1 171,326,218 $40,468,172,998 -$1,011,646,914 $236.38 1,071
2018 Q4 175,003,235 $52,619,725,529 -$839,325,018 $300.92 1,135
2018 Q3 177,270,767 $62,594,382,952 -$269,008,690 $353.31 1,140
2018 Q2 178,340,992 $51,731,992,582 -$2,444,250,744 $290.24 1,087
2018 Q1 186,913,555 $51,164,896,552 -$488,678,007 $273.82 1,096
2017 Q4 188,568,529 $60,044,982,772 +$9,889,834 $318.57 1,120
2017 Q3 188,385,830 $58,970,231,587 +$472,002,826 $313.12 1,011
2017 Q2 187,380,108 $50,837,222,531 +$288,984,209 $271.36 991
2017 Q1 188,211,491 $51,456,575,196 +$4,118,247,453 $273.42 1,016
2016 Q4 189,394,911 $53,679,916,033 -$1,015,070,941 $283.58 1,021
2016 Q3 191,778,014 $60,010,956,983 +$480,242,801 $313.03 1,007
2016 Q2 190,842,498 $46,263,524,155 -$112,555,041 $241.82 957
2016 Q1 190,858,170 $49,747,381,290 -$388,687,634 $260.32 938
2015 Q4 192,339,308 $59,013,396,053 -$2,589,949,247 $306.35 965
2015 Q3 200,266,975 $58,440,502,406 -$3,822,036,876 $291.81 914
2015 Q2 211,110,431 $85,274,602,341 -$1,015,846,158 $403.94 961
2015 Q1 213,693,704 $90,176,303,862 +$321,462,904 $422.24 961
2014 Q4 213,378,369 $72,452,156,965 -$502,527,627 $339.45 877
2014 Q3 214,442,358 $70,936,086,109 -$177,791,858 $330.81 811
2014 Q2 214,744,481 $67,717,564,176 +$911,109,846 $315.31 777
2014 Q1 212,004,121 $64,813,130,089 -$390,248,896 $305.87 767